| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6016737 | European Journal of Paediatric Neurology | 2015 | 7 Pages |
Abstract
Our study suggests that LTG, VPA and CBZ can be used as drugs of first choice in Rett Syndrome. The association of four drugs should be avoided since it did not result in any significant clinical improvement.
Related Topics
Life Sciences
Neuroscience
Developmental Neuroscience
Authors
Maria Pintaudi, Maria Grazia Calevo, Aglaia Vignoli, Maria Giuseppina Baglietto, Yussef Hayek, Maria Traverso, Thea Giacomini, Lucio Giordano, Alessandra Renieri, Silvia Russo, MariaPaola Canevini, Edvige Veneselli,